Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers

Journal of Breath Research

Volumn 8, Issue 2, 2014, Pages

  Filipiak, Wojciech ^a,b   Filipiak, Anna ^a,b   Sponring, Andreas ^a,b   Schmid, Thomas ^c   Zelger, Bettina ^d   Ager, Clemens ^a,b   Klodzinska, Ewa ^e   Denz, Hubert ^a,c   Pizzini, Alex ^c   Lucciarini, Paolo ^c   Jamnig, Herbert ^c   Troppmair, Jakob ^b   Amann, Anton ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e Department of Elastomers and Rubber Technology   (Poland)

Author keywords

adsorptive preconcentration; breath analysis; breath markers; cancer cell lines; GC MS; lung cancer; tumor tissue

Indexed keywords

2 BUTANONE; 2 HEXANONE; 2 METHYL 1 PENTENE; 2 PROPANOL; 2,3 BUTANEDIONE; 2,3,4 TRIMETHYLPENTANE; 2,4 DIMETHYLHEPTANE; 4 METHYLHEPTANE; 4 METHYLOCTANE; 6 METHYL 5 HEPTEN 2 ONE; ACETALDEHYDE; ACETIC ACID; ACETONITRILE; ACROLEIN; ALCOHOL; BENZALDEHYDE; CROTONALDEHYDE; DODECANE; HEXANAL; HEXANE; INTER ALIA 2 METHYLPENTANE; ISOVALERALDEHYDE; NONANE; OCTANE; PENTANE; PROPIONALDEHYDE; PROPYLENE; PYRIDINE; PYRROLE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; EXPIRED AIR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SARCOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; TRANSFORMED CELL LINE; VERY ELDERLY; CASE CONTROL STUDY; COMPARATIVE STUDY; EXHALATION; LUNG; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; SMOKING;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL LINE, TRANSFORMED; EXHALATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SMOKING; TUMOR MARKERS, BIOLOGICAL; VOLATILE ORGANIC COMPOUNDS;

EID: 84901640017     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/8/2/027111     Document Type: Article

References (76)

1. Siegel R, Ma J, Zou Z and Jemal A 2014 Cancer statistics CA: Cancer J. Clin. 64 9-29
2. Detterbeck F C, Boffa D J and Tanoue L T 2009 The new lung cancer staging system Chest 136 260-71
3. Damhuis R A and Schutte P R 1996 Resection rates and postoperative mortality in 7,899 patients with lung cancer Eur. Respir. J. 9 7-10 (Pubitemid 26037523)
4. Little A G, Rusch V W, Bonner J A, Gaspar L E, Green M R, Webb W R and Stewart A K 2005 Patterns of surgical care of lung cancer patients Ann. Thorac. Surg. 80 2051-6 discussion 2056
5. Little A G, Gay E G, Gaspar L E and Stewart A K 2007 National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care Lung Cancer 57 253-60 (Pubitemid 47285417)
6. Mazzone P J and Mekhail T 2007 Lung cancer screening Curr. Oncol. Rep. 9 265-74 (Pubitemid 47045161)
7. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B and Prorok P 2004 Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan versus chest radiograph: the lung screening study of the national cancer institute Chest 126 114-21 (Pubitemid 38943126)
8. Infante M et al 2009 A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial Am. J. Respir. Crit. Care Med. 180 445-53
9. Henschke C I, Yankelevitz D F, Libby D M, Pasmantier M W, Smith J P and Miettinen O S 2006 Survival of patients with stage I lung cancer detected on CT screening N Engl. J. Med. 355 1763-71 (Pubitemid 44631359)
10. Maziak D E et al 2009 Positron emission tomography in staging early lung cancer: a randomized trial Ann. Intern. Med. 151 221-8 W-48
11. Silvestri G A, Gould M K, Margolis M L, Tanoue L T, McCrory D, Toloza E and Detterbeck F 2007 Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edn) Chest 132 178
12. Detterbeck F C, Mazzone P J, Naidich D P and Bach P B 2013 Screening for lung cancer Diagnosis and Management of Lung Cancer (3rd edn: American College of Chest Physicians evidence based clinical practice guidelines) Chest 143 Suppl 5 e78S-92S
13. Bach P B 2013 Perilous potential: the chance to save lives, or lose them, through low dose computed tomography screening for lung cancer J. Surg. Oncol. 108 287-8
14. Aberle D R, Adams A M, Berg C D, Black W C, Clapp J D, Fagerstrom R M, Gareen I F, Gatsonis C, Marcus P M and Sicks J D 2011 Reduced lung-cancer mortality with low-dose computed tomographic screening N. Engl. J. Med. 365 395-409
15. Bach P B et al 2012 Benefits and harms of CT screening for lung cancer: a systematic review JAMA 307 2418-29
16. Smith-Bindman R et al 2012 Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010 JAMA 307 2400-9
17. Cope K A 2005 Breath ethane in disease: methods for analysis based on room air correction Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring ed A Amann and D Smith (Singapore: World Scientific) pp 237-47
18. Amann A, Spanel P and Smith D 2007 Breath analysis: the approach towards clinical applications Mini. Rev. Med. Chem. 7 115-29 (Pubitemid 46592175)
19. Risby T 2005 Current status of clinical breath analysis Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring ed A Amann and D Smith (Singapore: World Scientific) pp 251-65
20. 13C-octanoic acid breath test in measuring human solid gastric emptying J. Gastroenterol. Hepatol. 18 41-6
21. 13C-urea Aliment. Pharmacol. Ther. 16 787-92
22. Alving K, Weitzberg E and Lundberg J M 1993 Increased amount of nitric oxide in exhaled air of asthmatics Eur. Respir. J. 6 1368-70 (Pubitemid 23329557)
23. Kharitonov S A, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E A and Barnes P J 1994 Increased nitric oxide in exhaled air of asthmatic patients Lancet 343 133-5 (Pubitemid 24028638)
24. Phillips M et al 2007 Prediction of lung cancer using volatile biomarkers in breath Cancer Biomarkers 3 95-109 (Pubitemid 47103811)
25. Phillips M, Cataneo R N, Cummin A R, Gagliardi A J, Gleeson K, Greenberg J, Maxfield R A and Rom W N 2003 Detection of lung cancer with volatile markers in the breath Chest 123 2115-23 (Pubitemid 36706741)
26. Phillips M, Cataneo R N, Ditkoff B A, Fisher P, Greenberg J, Gunawardena R, Kwon C S, Rahbari-Oskoui F and Wong C 2003 Volatile markers of breast cancer in the breath Breast J. 9 184-91 (Pubitemid 36627163)
27. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grabmer C, Gastl G and Amann A 2007 Lung cancer detection by proton transfer reaction mass spectrometric analysis of human breath gas Int. J. Mass Spectrom. 265 49-59
28. Machado R F et al 2005 Detection of lung cancer by sensor array analyses of exhaled breath Am. J. Respir. Crit. Care Med. 171 1286-91 (Pubitemid 40740737)
29. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, Finazzi-Agro A and D'Amico A 2003 Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors Biosens. Bioelectron. 18 1209-18 (Pubitemid 36776581)
30. Bajtarevic A et al 2009 Noninvasive detection of lung cancer by analysis of exhaled breath BMC Cancer 9 348
31. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, Bianchi L, Rusca M and Mutti A 2005 Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Respir. Res. 6 71
32. Amann A et al 2010 Analysis of exhaled breath for screening of lung cancer patients Mag. Eur. Med. Oncol. 3 106-12
33. Haick H, Broza Y Y, Mochalski P, Ruzsanyi V and Amann A 2014 Assessment, origin, and implementation of breath volatile cancer markers Chem. Soc. Rev. 43 1423-49
34. Hakim M, Broza Y Y, Barash O, Peled N, Phillips M, Amann A and Haick H 2012 Volatile organic compounds of lung cancer and possible biochemical pathways Chem. Rev. 112 5949-66
35. Kischkel S, Miekisch W, Sawacki A, Straker E M, Trefz P, Amann A and Schubert J K 2010 Breath biomarkers for lung cancer detection and assessment of smoking related effects-confounding variables, influence of normalization and statistical algorithms Clin. Chim. Acta 411 1637-44
36. Haick H, Broza Y Y, Mochalski P, Ruzsanyi V and Amann A 2013 Assessment, origin, and implementation of breath volatile cancer markers Chem. Soc. Rev. 43 1423-49
37. de Lacy Costello B, Amann A, Al-Kateb H, Flynn C, Filipiak W, Khalid T, Osborne D and Ratcliffe N M 2014 A review of the volatiles from the healthy human body J Breath Res. 8 014001
38. Filipiak W, Sponring A, Bauer M, Filipiak A, Ager C, Wiesenhofer H, Nagl M, Troppmair J and Amann A 2012 Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa BMC Microbiol. 12 113
39. Filipiak W, Sponring A, Baur M M, Ager C, Filipiak A, Wiesenhofer H, Nagl M, Troppmair J and Amann A 2012 Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS Microbiology 158 3044-53
40. Filipiak W S A, Filipiak A, Baur M, Ager C, Wiesenhofer H, Margesin R, Nagl M, Troppmair J and Amann A 2013 Volatile organic compounds (VOCs) released by pathogenic microorganisms in vitro: potential breath biomarkers for early-stage diagnosis of disease Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine ed A S Amann (Gurgaon: Elsevier) pp 475-524
41. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol. Biomarkers Prev. 19 182-95
42. Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int. 8 17
43. Sponring A, Filipiak W, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2010 Analysis of volatile organic compounds (VOCs) in the headspace of NCIH1666 lung cancer cells in vitro Cancer Biomarkers 7 1-9
44. Sponring A, Filipiak W, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A and Troppmair J 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro Anticancer Res. 29 419-26
45. Mirsadraee S, Oswal D, Alizadeh Y, Caulo A and van Beek E Jr 2012 The 7th lung cancer TNM classification and staging system: review of the changes and implications World J. Radiol. 4 128-34
46. Fastyn P, Kornacki W, Gierczak T, Gawlowski J and Niedzielski J 2005 Adsorption of water vapour from humid air by selected carbon adsorbents J. Chromatogr. A 1078 7-12 (Pubitemid 40813092)
47. Gawrys M, Fastyn P, Gawlowski J, Gierczak T and Niedzielski J 2001 Prevention of water vapour adsorption by carbon molecular sieves in sampling humid gases J. Chromatogr. A 933 107-16 (Pubitemid 33043746)
48. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H and Amann A Physiological modeling of isoprene dynamics in exhaled breath J. Theor. Biol. 267 626-37
49. King J, Kupferthaler A, Unterkofler K, Koc H, Teschl S, Teschl G, Miekisch W, Schubert J, Hinterhuber H and Amann A 2009 Isoprene and acetone concentration profiles during exercise on an ergometer J. Breath Res. 3 027006
50. King J, Mochalski P, Kupferthaler A, Unterkofler K, Koc H, Filipiak W, Teschl S, Hinterhuber H and Amann A 2010 Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study Physiol. Meas. 31 1169-84
51. King J, Mochalski P, Unterkofler K, Teschl G, Klieber M, Stein M, Amann A and Baumann M 2012 Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body Biochem. Biophys. Res. Commun. 423 526-30
52. Mochalski P, King J, Unterkofler K and Amann A 2013 Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags Analyst 138 1405-18
53. Mochalski P, Wzorek B, Sliwka I and Amann A 2009 Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis J. Chromatogr. B 877 189-96
54. Mochalski P, Wzorek B, Sliwka I and Amann A 2009 Improved pre-concentration and detection methods for volatile sulphur breath constituents J. Chromatogr. B 877 1856-66
55. Filipiak W, Filipiak A, Ager C, Wiesenhofer H and Amann A 2012 Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps J. Breath Res. 6 027107
56. Buszewski B, Ligor T, Filipiak W, Vasconcelos MT, Pompe M and Veber M 2007 Study of sorptive properties of trap systems for selective enrichment of volatile organic compounds from tobacco smoke samples Toxicol. Environ. Chem. 1 51-64 (Pubitemid 350249216)
57. Filipiak W et al 2012 Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants J. Breath Res. 6 036008
58. Kleinbaum D, Kupper L, Muller A and Nizam K 1998 Applied Regression Analysis and Other Multivariable Methods (Pacific Grove, CA: Brooks/Cole Publishing Company)
59. Yu C and Crump D 1998 A review of the emission of VOCs from polymeric materials used in buildings Build. Environ. 33 357-74 (Pubitemid 128369062)
60. Ullrich F and Grosch W 1987 Identification of the most intense volatile flavour compounds formed during autoxidation of linoleic acid Z. Lebensmittel-Untersuchung Forsch. 184 277-82
61. Uhde E and Salthammer T 2007 Impact of reaction products from building materials and furnishings on indoor air quality - a review of recent advances in indoor chemistry Atmos. Environ. 41 3111-28 (Pubitemid 46533949)
62. Mochalski P, King J, Klieber M, Unterkofler K, Hinterhuber H, Baumann M and Amann A 2013 Blood and breath levels of selected volatile organic compounds in healthy volunteers Analyst 138 2134-45
63. Mochalski P, King J, Haas M, Unterkofler K, Amann A and Mayer G 2014 Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease BMC Nephrology 15 43
64. Erhart S, Amann A, Karall D, Edlinger G, Haberlandt E, Schmid A, Filipiak W, Mochalski P, Rostasy K and Scholl-Bürgi S 2009 3-Heptanone as a potential new marker for valproic acid therapy J. Breath Res. 3 016004
65. Birken T, Schubert J, Miekisch W and Noldge-Schomburg G 2006 A novel visually CO2 controlled alveolar breath sampling technique Technol. Health Care 14 499-506 (Pubitemid 44885294)
66. Cope K A, Watson M T, Foster W M, Sehnert S S and Risby T H 2004 Effects of ventilation on the collection of exhaled breath in humans J. Appl. Physiol. 96 1371-9 (Pubitemid 38392673)
67. Schubert J K, Spittler K H, Braun G, Geiger K and Guttmann J 2001 CO(2)-controlled sampling of alveolar gas in mechanically ventilated patients J. Appl. Physiol. 90 486-92 (Pubitemid 32118907)
68. Miekisch W, Kischkel S, Sawacki A, Liebau T, Mieth M and Schubert J K 2008 Impact of sampling procedures on the results of breath analysis J. Breath Res. 2 026007
69. Mochalski P, Sponring A, King J, Unterkofler K, Troppmair J and Amann A 2013 Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro Cancer Cell Int. 13 72
70. Buszewski B, Ulanowska A, Ligor T, Jackowski M, Klodzinska E and Szeliga J 2008 Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures J. Chromatogr. B 868 88-94
71. Amal H et al 2012 The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs) Int. J. Nanomed. 7 4135-46
72. Broza Y Y, Kremer R, Tisch U, Gevorkyan A, Shiban A, Best L A and Haick H 2013 A nanomaterial-based breath test for short-term follow-up after lung tumor resection Nanomedicine 9 15-21
73. Fuchs P, Loeseken C, Schubert J K and Miekisch W 2010 Breath gas aldehydes as biomarkers of lung cancer Int. J. Cancer 126 2663-70
74. Phillips M, Cataneo R N, Greenberg J, Grodman R, Gunawardena R and Naidu A 2003 Effect of oxygen on breath markers of oxidative stress Eur. Respir. J. 21 48-51 (Pubitemid 36150300)
75. Kneepkens C M, Lepage G and Roy C C 1994 The potential of the hydrocarbon breath test as a measure of lipid peroxidation Free Radic. Biol. Med. 17 127-60 (Pubitemid 24217183)
76. Mitsui T and Kondo T 2003 Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress Clin. Chim. Acta 333 91